Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127030901 | 12703090 | 1 | I | 20160826 | 20160829 | 20160831 | 20160831 | PER | US-GLAXOSMITHKLINE-US2016125751 | GLAXOSMITHKLINE | 83.76 | YR | F | Y | 0.00000 | 20160831 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127030901 | 12703090 | 1 | PS | LOVAZA | OMEGA-3-ACID ETHYL ESTERS | 1 | Oral | 1 DF, BID | 21654 | 1 | DF | CAPSULE | BID | ||||||
| 127030901 | 12703090 | 2 | SS | Omega-3-acid ethyl esters Capsule | OMEGA-3-ACID ETHYL ESTERS | 1 | Oral | Y | 21654 | 1 | DF | CAPSULE | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127030901 | 12703090 | 1 | Blood cholesterol increased |
| 127030901 | 12703090 | 2 | Blood cholesterol increased |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127030901 | 12703090 | Eructation |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127030901 | 12703090 | 1 | 2006 | 0 |